Login
From:
Vividion Therapeutics
(Uncensored)
subscribe
Vividion Therapeutics and Bayer Further Strengthen Oncology Development Pipeline with Clinical-Stage WRN Inhibitor — Vividion Therapeutics
https://vividion.com/news/vividion-therapeutics-and-bayer-further-strengthen-oncology-development-pipeline-with-clinical-stage-wrn-inhibitor/
links
backlinks
Tagged with:
press releases
Roast topics
Find topics
Find it!
VVD-214 is the only clinical-stage covalent inhibitor of Werner helicase (WRN) in development worldwide WRN inhibition may provide therapeutic benefit in
